1
Shankar Venkatraman, Khurram P Sheikh: System and method for performance enhancement in heterogeneous wireless access network employing distributed antenna system. Intel Corporation, Schwegman Lundberg & Woessner P A, Anthony P Curtis, April 28, 2015: US09020555 (109 worldwide citation)

A system and method for dynamically optimizing the performance of indoor distributed antenna systems communicate to user equipment is disclosed. The user equipment measures information describing the downlink signals such as the downlink data rates, the quality of the received signal, and the locati ...


2
Shankar Venkatraman, Khurram P Sheikh: System and method for performance enhancement in heterogeneous wireless access network employing band selective power management. Intel Corporation, Schwegman Lundberg & Woessner P A, June 7, 2016: US09363761 (108 worldwide citation)

A system and method for enhancing the performance in heterogeneous wireless access networks employing a distributed antenna system is disclosed. A control unit comprises a distributed antenna system management server which collects load information from each of the carriers. The control unit further ...


3

4
Clifford M Bryant, James T Palmer, Robert M Rydzewski, Eduardo L Setti, Zong Qiang Tian, Shankar Venkatraman, Dan Xiong Wang: Compounds and compositions as protease inhibitors. Axys Pharmaceuticals, Townsend and Townsend and Crew, November 5, 2002: US06476026 (9 worldwide citation)

The present invention relates to novel N-cyanomethyl amides which are cysteine protease inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.


5
Salvacion Cacatian, David A Claremon, Lawrence W Dillard, Klaus Fuchs, Niklas Heine, Lanqi Jia, Katerina Leftheris, Brian McKeever, Angel Morales Ramos, Suresh B Singh, Shankar Venkatraman, Guosheng Wu, Zhongren Wu, Zhenrong Xu, Jing Yuan, Yajun Zheng: Inhibitors of beta-secretase. Vitae Pharmaceuticals, Boehringer Ingelheim International, McCarter & English, Steven G Davis, Emily Dertz, January 21, 2014: US08633212 (6 worldwide citation)

The present invention is directed to a compound represented by the following structural formula or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also described.


6
Clifford M Bryant, James T Palmer, Robert M Rydzewski, Eduardo L Setti, Zong Qiang Tian, Shankar Venkatraman, Dan Xiong Wang: Compounds and compositions as protease inhibitors. Axys Pharmaceuticals, Townsend and Townsend and Crew, July 15, 2003: US06593327 (3 worldwide citation)

The present invention relates to novel N-cyanomethyl amides which are cysteine protease inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.


7
Yuri Bukhtiyarov, Salvacion Cacatian, Lawrence Wayne Dillard, Cornelia Dorner Ciossek, Klaus Fuchs, Lanqi Jia, Deepak S Lala, Angel Morales Ramos, Jonathan Reeves, Suresh B Singh, Shankar Venkatraman, Zhenrong Xu, Jing Yuan, Yi Zhao, Yajun Zheng, Georg Rast: Inhibitors of β-secretase. Vitae Pharmaceuticals, Boehringer Ingelheim International, McCarter & English, Steven G Davis, Xin Zhang, March 17, 2015: US08981112 (2 worldwide citation)

The present invention relates to spirocyclic acylguanidines and their use as inhibitors of the β-secretase enzyme (BACE1) activity, pharmaceutical compositions containing the same, and methods of using the same as therapeutic agents in the treatment of neurodegenerative disorders, disorders characte ...


8
Yuri Bukhtiyarov, Salvacion Cacatian, Lawrence Wayne Dillard, Klaus Fuchs, Lanqi Jia, Deepak S Lala, Angel Morales Ramos, Suresh B Singh, Shankar Venkatraman, Zhenrong Xu, Jing Yuan, Yi Zhao, Yajun Zheng, Cornelia Dorner Ciossek, Ulrike Gross, Niklas Heine, Achim Sauer: Inhibitors of beta-secretase. Boehringer Ingelheim International, Vitae Pharmaceuticals, McCarter & English, Steven G Davis, Xin Zhang, April 28, 2015: US09018391 (1 worldwide citation)

The present invention relates to spirocyclic acylguanidines and their use as inhibitors of the β-secretase enzyme (BACE1) activity, pharmaceutical compositions containing the same, and methods of using the same as therapeutic agents in the treatment of neurodegenerative disorders, disorders characte ...


9
Lawrence Wayne Dillard, Jing Yuan, Katerina Leftheris, Shankar Venkatraman, Guosheng Wu, Lanqi Jia, Zhenrong Xu, Salvacion Cacatian, Angel Morales Ramos, Suresh B Singh, Yajun Zheng: Inhibitors of beta-secretase. Vitae Pharmaceuticals, McCarter & English, Steven G Davis, Xin Zhang, June 2, 2015: US09045500 (1 worldwide citation)

The present invention relates to compounds represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. Definitions for the variables are provided herein.


10
Sairamesh Nammi, Shankar Venkatraman, Gaurav Hemrajani, Ashvin Chheda, Lai King Tee, Neng Wang, Kathiravetpillai Sivanesan: Including feedback information regarding an individual subband of a wireless channel. Apple, Meyertons Hood Kivlin Kowert & Goetzel P C, November 3, 2015: US09178594 (1 worldwide citation)

To report feedback information regarding a wireless channel, a mobile station determines whether a predefined condition is satisfied. In response to determining that the predefined condition is satisfied, feedback information regarding an individual one of plural subbands of the wireless channel is ...